Patent holdings for IPC class C12N 15/113

Total number of patents in this class: 24029

10-year publication summary

1595
1794
1796
1969
2318
2305
2629
2716
2734
961
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1062
631
Ionis Pharmaceuticals, Inc.
781
528
The Regents of the University of California
18992
480
University of Massachusetts
2131
356
Massachusetts Institute of Technology
9804
232
Inserm (institut National de La Sante et de La Recherche Medicale)
3316
211
President and Fellows of Harvard College
5797
210
Dicerna Pharmaceuticals, Inc.
279
200
Arrowhead Pharmaceuticals, Inc.
219
168
Regeneron Pharmaceuticals, Inc.
3692
168
Monsanto Technology LLC
7977
167
The General Hospital Corporation
4541
163
The Broad Institute, Inc.
1592
163
Centre National de La Recherche Scientifique
9640
159
The Board of Trustees of the Leland Stanford Junior University
6076
146
Sarepta Therapeutics, Inc.
354
143
Hoffmann-La Roche Inc.
3079
132
CuRNA, Inc.
146
131
City of Hope
944
118
Board of Regents, The University of Texas System
5406
117
Other owners 19406